Athos Therapeutics, Inc.
New Filing
CIK: 0001885079·Pharmaceuticals·DELAWARE·Filed: Feb 6, 2024
Total Offering
$34,999,995
Amount Sold
$7,556,334
Investors
30
First Sale
Jan 22, 2024
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506(b)
Related Persons
| Name | Role |
|---|---|
| Dimitrios Iliopoulos | Executive Officer, Director |
| Allan J. Pantuck | Executive Officer, Director |
| Carl McKinzie | Director |
| Joel Cohen | Director |
| Anthony Zingale | Director |
Company
SEC Filing
0001885079-24-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free